# Novartis (Switzerland)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/novartis-switzerland/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 53.8 |
| Citations | 5,710,079 |
| City | Basel |
| Country | CH |
| Description | Novartis (Switzerland) is a research organisation in Basel, CH. OpenAlex records 36,463 works and 5,710,079 citations for it. 9,312 researchers list it as their most recent affiliation. |
| Homepage | https://www.novartis.com/ |
| OpenAlex ID | https://openalex.org/I1283582996 |
| Region | Basel-City |
| Researchers | 9,312 |
| ROR ID | https://ror.org/02f9zrr09 |
| Type | company |
| Works | 36,463 |

## University papers

Showing 12 of 232.

- [The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity](https://scholariq.org/papers/the-cancer-cell-line-encyclopedia-enables-predictive-modelling-of-anticancer/)
- [Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure](https://scholariq.org/papers/angiotensin-neprilysin-inhibition-versus-enalapril-in-heart-failure/)
- [2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk](https://scholariq.org/papers/2013-acc-aha-guideline-on-the-assessment-of-cardiovascular-risk/)
- [Identification and Importance of Brown Adipose Tissue in Adult Humans](https://scholariq.org/papers/identification-and-importance-of-brown-adipose-tissue-in-adult-humans/)
- [Heart Disease and Stroke Statistics—2009 Update](https://scholariq.org/papers/heart-disease-and-stroke-statistics-2009-update-2/)
- [2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk](https://scholariq.org/papers/2013-acc-aha-guideline-on-the-assessment-of-cardiovascular-risk-2/)
- [Defining the clinical course of multiple sclerosis](https://scholariq.org/papers/defining-the-clinical-course-of-multiple-sclerosis/)
- [Heart Disease and Stroke Statistics—2009 Update](https://scholariq.org/papers/heart-disease-and-stroke-statistics-2009-update/)
- [Cross-Validation of Item Selection and Scoring for the SF-12 Health Survey in Nine Countries](https://scholariq.org/papers/cross-validation-of-item-selection-and-scoring-for-the-sf-12-health-survey-in/)
- [Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction](https://scholariq.org/papers/angiotensin-neprilysin-inhibition-in-heart-failure-with-preserved-ejection/)
- [Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk](https://scholariq.org/papers/genetic-variants-in-novel-pathways-influence-blood-pressure-and-cardiovascular/)
- [Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients](https://scholariq.org/papers/benazepril-plus-amlodipine-or-hydrochlorothiazide-for-hypertension-in-high-risk/)

## University researchers

- [Jashin J. Wu](https://scholariq.org/researchers/jashin-j-wu/)
- [Abhijit Gadkari](https://scholariq.org/researchers/abhijit-gadkari/)
- [Nigel S. Cook](https://scholariq.org/researchers/nigel-s-cook/)
- [Santiago G. Moreno](https://scholariq.org/researchers/santiago-g-moreno/)
- [Vera Golder](https://scholariq.org/researchers/vera-golder/)
- [Serge Smeets](https://scholariq.org/researchers/serge-smeets/)
- [Alexandros Sagkriotis](https://scholariq.org/researchers/alexandros-sagkriotis/)
- [K. Buesch](https://scholariq.org/researchers/k-buesch/)
- [Michel Kroes](https://scholariq.org/researchers/michel-kroes/)
- [Mark Pletscher](https://scholariq.org/researchers/mark-pletscher/)
- [Briana Ndife](https://scholariq.org/researchers/briana-ndife/)
- [Clint W. Abner](https://scholariq.org/researchers/clint-w-abner/)
- [Carolina Aldworth](https://scholariq.org/researchers/carolina-aldworth/)

## University top topics

Showing 8 of 25.

- [Computational Drug Discovery Methods](https://scholariq.org/topics/computational-drug-discovery-methods/)
- [Chemical Synthesis and Analysis](https://scholariq.org/topics/chemical-synthesis-and-analysis/)
- [Statistical Methods in Clinical Trials](https://scholariq.org/topics/statistical-methods-in-clinical-trials/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Neuroscience and Neuropharmacology Research](https://scholariq.org/topics/neuroscience-and-neuropharmacology-research/)
- [Receptor Mechanisms and Signaling](https://scholariq.org/topics/receptor-mechanisms-and-signaling/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Analytical Chemistry and Chromatography](https://scholariq.org/topics/analytical-chemistry-and-chromatography/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.